Specifically, we established for the first time that the inhibition of LRRK2 kinase activity attenuates the induction of IL-1β cytokine and favors the clearance of Aβ1-42 fibrils, suggesting that LRRK2-related astrocytic functions might contribute to AD pathology. Here, LRRK2 is linked to Alzheimer disease.